Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03808064
Other study ID # ADS18
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 17, 2019
Est. completion date December 26, 2020

Study information

Verified date December 2021
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to evaluate the effect of a Female Community Health Volunteer (FCHV) led community-based educational intervention through home visits increasing cervical cancer screening uptake.


Description:

Cervical cancer is the major cause of cancer deaths among women in Nepal. Screening is one of the most effective tools for early diagnosis, prevention, and treatment. However, skilled health professionals and tools available for cervical cancer screening are limited in low and middle-income countries (LMICs) including Nepal. The World Health Organization (WHO) and Alliance for Cervical Cancer Prevention (ACCP) recommends that countries, areas, or institutions seeking to initiate or strengthen cervical cancer screening programs should consider introducing or expanding Visual Inspection with Acetic acid (VIA) until more appropriate and affordable HPV-based tests become available. 'National Guideline for Cervical Cancer Screening and Prevention in Nepal, 2010' includes VIA as a screening method for cervical cancer. Current studies reveal Nepalese women's participation in cervical cancer screening is low. Thus, there is a need for appropriate, cost-effective and sustainable interventions to increase VIA screening uptake at the primary health care level across Nepal. The primary objective of this study is to evaluate the effect of a Female Community Health Volunteer (FCHV) led community-based educational intervention through home visits increasing cervical cancer screening uptake. The primary outcome of the study is to increase the cervical cancer-screening uptake in the intervention group. This will be the first community-based cluster-randomized trial designed to mobilize FCHVs for increasing cervical cancer screening uptake in Nepal.


Recruitment information / eligibility

Status Completed
Enrollment 690
Est. completion date December 26, 2020
Est. primary completion date December 26, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - All women of age group 30-60 years who were recruited in the COBIN Wave I survey Exclusion Criteria: - Women who are not able to give consent - Severely ill, - Pregnant or less than 6 weeks after delivery, - Who is already diagnosed with cervical pre-cancer and cancer - With a history of total hysterectomy - Who are reluctant to participate in the study or unable to complete the interview

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
FCHV home visit
Behavioral: FCHV visit Female Community Health Volunteer will visit selected households 3 times a year for providing health promotion messages Other Name: FCHV Home Visit

Locations

Country Name City State
Nepal Nepal Development Society Pokhara Gandaki

Sponsors (1)

Lead Sponsor Collaborator
University of Aarhus

Country where clinical trial is conducted

Nepal, 

Outcome

Type Measure Description Time frame Safety issue
Primary The increase in the number of participants attending cervical cancer screening after education intervention The effect of Female Community Health Volunteers led community based educational intervention through home visits for increasing cervical cancer screening uptake will be evaluated by comparing the baseline with follow up study. One year
See also
  Status Clinical Trial Phase
Recruiting NCT05092022 - St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic N/A
Recruiting NCT04965857 - Comparison of the Hologic Genius Digital Diagnostics System With the Liquid-based Cytology (LBC) Manual Microscopy
Completed NCT00933140 - Anal HPV Infection and Abnormal Cytology in HIV-infected Women N/A
Recruiting NCT05314907 - Acceptability of Self-sampling for Cervical Cancer Screening N/A
Recruiting NCT04650711 - Immunohistochemical Staining of p16 for the Screening of Cervical Cancer Phase 2
Recruiting NCT06178549 - Emergency Room HPV Self-Sampling Study (ACT NOW) N/A
Recruiting NCT06204133 - Model Study on Cervical Cancer Screening Strategies and Risk Prediction
Completed NCT04237883 - Primary Care Clinical Excellence Incentive Study N/A
Not yet recruiting NCT03750214 - Evaluation of the Biop Colposcopy System's Safety and Performance (Accuracy of Its Registration Procedure) N/A
Completed NCT03222817 - HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals N/A
Not yet recruiting NCT05426642 - The Effect of E-health Video Towards Enhancing Cervical Cancer Screening N/A
Completed NCT00461760 - HPV Testing for Cervical Cancer Screening Study N/A
Not yet recruiting NCT05286034 - Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme N/A
Recruiting NCT05256862 - Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania
Recruiting NCT05762757 - Patient-centered Educational Material to Improve Colposcopy Adherence N/A
Completed NCT02273206 - Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women N/A
Completed NCT03466710 - Post Colposcopy Management of ASC-US and LSIL Pap Tests N/A
Completed NCT01287871 - Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer N/A
Completed NCT00224224 - A Comparison of Primary Care and Traditional Internal Medicine Residents N/A
Not yet recruiting NCT06229275 - Study to Evaluate the Effectiveness of the Personal Pap Smear Deviceā„¢ for Collection of Cervical Cells Phase 3